Galileo Life Sciences, Inc. Reports Termination of Option Agreement With Easton Pharmaceuticals

Galileo Life Sciences, Inc. (‘the Company”) (OTC PINK: MDRM) formerly known as Modern Mobility Aids Inc. announced today that as a result of several breaches of agreement, it has terminated its option agreement with Easton Pharmaceuticals of Toronto. Contrary to press releases on June 1, 2015 and June 17, 2015 by Easton... more →
Posted in: Press

Easton Pharmaceuticals Announces Mexican Ministry of Health Filing and Approval Process for Cancer Drugs

Easton Pharmaceuticals / BMV Medica Announces Its Mexican Ministry of Health and Latin America Regulatory Filing and Approval Process for Cancer Drugs Paclitaxel and Docetaxel From Biolyse Pharma Has Been Shortened Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces positive update from Ackerman Pharma; where the regulatory filing... more →
Posted in: Press

Easton Pharmaceuticals Signs MOU Towards Distributing Cancer Drugs for Mexico

Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has signed an MOU agreement towards finalizing negotiations with BMV Medica S.A. de C.V. to jointly distribute and sell a line of the most common and used cancer drugs throughout Mexico and most of Latin America. The majority of these sales will be to the Mexican and other... more →
Posted in: Press

Easton Pharmaceuticals Announces Memorandum of Understanding With Broken Coast Cannabis Ltd.

Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces a Memorandum Of Understanding with Broken Coast Cannabis  (http://www.brokencoast.ca/) — a licensed Health Canada Medical Marijuana provider under MMPR guidelines (http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/list-eng.php) and a company who also belongs to the Canadian... more →
Posted in: Press

Easton Pharmaceuticals Finalizes Its 2013 Audited Financials

As previously stated, grower details are expected to be disclosed within the second week of December as per allowances made on due diligence documentation and agreements. Easton has been considering entering the lucrative Medical Marijuana industry mainly through the acquisition route. Current acquisition candidates have insisted... more →
Posted in: Investing

Easton Pharmaceuticals Announces Financing Update; Provides Additional Info Regarding Investments

Any financing may involve a co-listing on a Canadian Exchange, which if implemented would not affect the company’s current U.S listing on the OTC markets. Although the financial institution is looking into all parts of Easton’s business segments, the main Easton initiative the brokerage firm is looking towards investing... more →
Posted in: Investing

Easton Pharmaceuticals Provides Additional Documents On Due Diligence

A specialty pharmaceutical company that owns, designs, develops, and markets an array of topically-delivered drugs and therapeutic / cosmetic healthcare products, today announces financing update, provides due diligence documents towards financing from a Toronto, Canada-based brokerage firm. Easton Pharmaceuticals has over the past... more →
Posted in: News

Cbd Hemp Oil Product Potential Increases With Ongoing Clinical Studies

(OTC Pink: ERBB) has made a move toward securing and expanding its business model regarding age-related purchases via any automated device.The company has entered into an agreement with Robert Tomassi, owner of intellectual property (IP) that pre-dates, and may supersede patents owned by competing companies operating in a similar... more →
Posted in: Investing

Easton Pharmaceuticals Looking To Invest In Medical Marijuana Industry

Easton Pharmaceuticals on Thursday announced it is speeding up negotiations with an Ontario-based company toward forming a possible investment/partnership toward their medical marijuana initiatives, which includes participating in their government application for both a growers and distributorship license in Canada and other possible... more →
Posted in: Investing